ConMed CNMD
$46.56 +$0.18 (+0.39%)
Market closed · Nov 20, 8:10 pm ET · Last extended-hours $46.56 0.00%
Open$46.11
Prev close$46.38
Day range$45.94 – $48.00
Volume384.3K
Market cap$1.39B
P/E (TTM)19.3
Dividend yield–
Fundamentals
Latest reported quarter: Q3, ended Sep 2026
Revenue$335.56M-0.7% YoY
Operating profit$37.14M+212.7% YoY
Net profit$19.80M+592.4% YoY
Diluted EPS$0.66+633.3% YoY
Free cash flow$46.73M-3.7% YoY
Operating cash flow$49.41M
Revenue, last 8 quarters
Net profit, last 8 quarters
Diluted EPS by quarter
Free cash flow by quarter
Annual revenue
Profitability & balance sheet
Gross margin57.6%
Operating margin9.9%
Net margin5.4%
Return on equity7.1%
Return on assets3.2%
Return on invested capital5.2%
Current ratio1.49
Liabilities / assets54.0%
Cash & investments$47.97M
Total debt$815.87M
Net cash (debt)-$767.89M
Free cash flow / sales9.7%
Where the revenue comes from
Quarter 2026/Q3
By business line
Income statement
| Line item | 2026 Q3 | 2026 Q2 | 2026 Q1 | 2025 ANNUAL | 2025 Q4 |
|---|---|---|---|---|---|
| Total Revenue as Reported | $335.56M | $343.49M | $317.05M | $1.37B | $373.20M |
| Total Operating Revenue | $335.56M | $343.49M | $317.05M | $1.37B | $373.20M |
| Cost of Revenue | $146.41M | $146.03M | $133.60M | $624.25M | $154.91M |
| Gross Profit | $189.15M | $197.46M | $183.45M | $750.48M | $218.29M |
| Operating Expense | $152.00M | $161.05M | $158.03M | $647.85M | $181.66M |
| Selling and Admin Expenses | $136.42M | $145.55M | $141.70M | $591.97M | $166.76M |
| Research & Development | $15.59M | $15.50M | $16.33M | $55.88M | $14.90M |
| Operating Profit | $37.14M | $36.41M | $25.42M | $102.62M | $36.62M |
| Net Non-Operating Interest Income (Expense) | -$11.14M | -$7.88M | -$7.06M | -$31.09M | -$7.37M |
| Non-Operating Interest Expense | $11.14M | $7.88M | $7.06M | $31.09M | $7.37M |
| Pretax Profit | $26.01M | $31.35M | $18.36M | $71.12M | $29.25M |
| Tax | $6.21M | $8.28M | $4.53M | $24.06M | $12.51M |
| Net Profit | $19.80M | $23.07M | $13.83M | $47.06M | $16.74M |
| Profit from Continuing Operations | $19.80M | $23.07M | $13.83M | $47.06M | $16.74M |
| Net Income to Parent Company | $19.80M | $23.07M | $13.83M | $47.06M | $16.74M |
| Net Income to Common Stockholders | $19.80M | $23.07M | $13.83M | $47.06M | $16.74M |
| Basic EPS | $0.66 | $0.77 | $0.45 | $1.52 | $0.54 |
| Diluted EPS | $0.66 | $0.77 | $0.45 | $1.51 | $0.54 |
| Dividend Per Share | $0.00 | $0.00 | $0.00 | $0.60 | $0.00 |
| Other Income (Expense) | – | $2.83M | – | -$418,000.00 | $0.00 |
| Other Non-Operating Income (Expenses) | – | $2.83M | – | -$418,000.00 | $0.00 |
Balance sheet
| Line item | 2026 Q3 | 2026 Q2 | 2026 Q1 | 2025 ANNUAL | 2025 Q4 |
|---|---|---|---|---|---|
| Total Assets | $2.30B | $2.30B | $2.31B | $2.33B | $2.33B |
| Total Current Assets | $682.04M | $675.67M | $670.59M | $672.86M | $672.86M |
| Cash and Cash Equivalents & Short-Term Investments | $47.97M | $37.33M | $35.03M | $40.82M | $40.82M |
| -Cash and Cash Equivalents | $47.97M | $37.33M | $35.03M | $40.82M | $40.82M |
| Receivables | $233.91M | $239.77M | $228.66M | $247.83M | $247.83M |
| -Accounts Receivable | $233.91M | $239.77M | $228.66M | $247.83M | $247.83M |
| Inventory | $362.83M | $360.18M | $366.11M | $355.54M | $355.54M |
| Other Current Assets | $37.33M | $38.39M | $40.79M | $28.67M | $28.67M |
| Total Non-Current Assets | $1.62B | $1.62B | $1.64B | $1.65B | $1.65B |
| Net PPE | $108.77M | $110.14M | $111.96M | $113.33M | $113.33M |
| Goodwill and Other Intangible Assets | $1.35B | $1.36B | $1.38B | $1.39B | $1.39B |
| -Goodwill | $796.93M | $796.90M | $806.86M | $807.01M | $807.01M |
| -Other Intangible Assets | $556.63M | $564.42M | $573.80M | $582.05M | $582.05M |
| Other Non-Current Assets | $160.10M | $153.18M | $151.73M | $137.19M | $137.19M |
| Total Liabilities | $1.24B | $1.26B | $1.30B | $1.29B | $1.29B |
| Total Current Liabilities | $458.96M | $455.40M | $292.72M | $315.04M | $315.04M |
| Payables | $98.50M | $101.02M | $105.42M | $93.65M | $93.65M |
| -Accounts Payable | $98.50M | $101.02M | $105.42M | $93.65M | $93.65M |
| Short-Term Debt and Capital Lease Obligation | $180.11M | $177.20M | $711,000.00 | $712,000.00 | $712,000.00 |
| -Current Debt | $180.11M | $177.20M | $711,000.00 | $712,000.00 | $712,000.00 |
| Other Current Liabilities | $103.74M | $106.77M | $125.70M | $138.54M | $138.54M |
| Total Non-Current Liabilities | $785.58M | $803.52M | $1.00B | $977.61M | $977.61M |
| Long Term Debt and Capital Lease Obligation | $635.76M | $657.05M | $860.16M | $834.23M | $834.23M |
| -Long Term Debt | $635.76M | $657.05M | $860.16M | $834.23M | $834.23M |
| Non-Current Deferred Liabilities | $88.96M | $84.58M | $81.38M | $79.53M | $79.53M |
| Other Non-Current Liabilities | $60.86M | $61.88M | $63.02M | $63.85M | $63.85M |
| Total Equity | $1.06B | $1.04B | $1.02B | $1.03B | $1.03B |
| Stockholders' Equity | $1.06B | $1.04B | $1.02B | $1.03B | $1.03B |
| Capital Stock | $313,000.00 | $313,000.00 | $313,000.00 | $313,000.00 | $313,000.00 |
| -Common Stock | $313,000.00 | $313,000.00 | $313,000.00 | $313,000.00 | $313,000.00 |
| -Preferred Stock | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 |
| Additional Paid-In Capital | $518.45M | $513.46M | $508.49M | $503.20M | $503.20M |
| Retained Earnings | $645.46M | $625.67M | $602.59M | $588.77M | $588.77M |
| Less: Treasury Stock | -$60.13M | -$54.68M | -$49.04M | -$12.89M | -$12.89M |
| Gains/Losses Not Affecting Retained Earnings | -$44.18M | -$43.37M | -$44.69M | -$46.30M | -$46.30M |
| -Gross PPE | – | – | – | $429.96M | $429.96M |
| -Accumulated Depreciation | – | – | – | -$316.63M | -$316.63M |
| Non-Current Deferred Assets | – | – | – | $13.31M | $13.31M |
Cash flow
| Line item | 2026 Q3 | 2026 Q2 | 2026 Q1 | 2025 ANNUAL | 2025 Q4 |
|---|---|---|---|---|---|
| Operating Cash Flow | $49.41M | $37.10M | $13.47M | $170.69M | $46.34M |
| Net cash flow from continuing operations | $49.41M | $37.10M | $13.47M | $170.69M | $46.34M |
| Net Income from Continuing Operations | $19.80M | $23.07M | $13.83M | $47.06M | $16.74M |
| Gain/Loss from Continuing Operations | -$312,000.00 | -$2.19M | -$3.92M | $363,000.00 | $0.00 |
| Depreciation & Depletion & Amortization | $19.18M | $19.05M | $18.84M | $74.28M | $18.85M |
| Deferred Tax | $4.60M | $2.15M | $1.54M | $3.52M | $812,000.00 |
| Other Non-Cash Items | $1.22M | $942,000.00 | $2.00M | $28.60M | $20.99M |
| Change in Working Capital | -$980,000.00 | -$11.15M | -$24.31M | -$11.45M | -$16.02M |
| -Change in Receivables | $5.72M | -$11.35M | $18.61M | -$2.36M | -$22.67M |
| -Change in Inventory | -$1.89M | -$1.44M | -$12.27M | -$6.73M | $8.51M |
| -Change in Payables and Accrued Expense | $3.97M | $5.20M | -$10.67M | $5.16M | -$7.69M |
| -Change in Other Current Assets | -$13.26M | $532,000.00 | -$17.22M | -$13.16M | -$225,000.00 |
| -Change in Other Current Liabilities | $4.48M | -$4.09M | -$2.76M | $6.19M | $6.61M |
| Net cash flow from investing | -$1.87M | $11.57M | $4.11M | -$20.96M | -$7.11M |
| Net Cash Flow from Continuing Investing Activities | -$1.87M | $11.57M | $4.11M | -$20.96M | -$7.11M |
| Net PPE Purchase and Sale | -$2.68M | -$2.93M | -$2.89M | -$19.81M | -$5.11M |
| Net Business Purchase and Sale | $813,000.00 | $14.50M | $7.00M | – | – |
| Financing Cash Flow | -$36.96M | -$46.23M | -$22.55M | -$135.82M | -$37.37M |
| Net Cash Flow from Continuing Financing Activities | -$36.96M | -$46.23M | -$22.55M | -$135.82M | -$37.37M |
| Net Issuance Payments Of Debt | -$18.63M | -$19.18M | $25.00M | -$74.59M | -$20.00M |
| Net Common Stock Issuance | -$6.20M | -$6.20M | -$37.02M | – | – |
| Cash Dividends Paid | $0.00 | $0.00 | $0.00 | -$24.75M | -$6.19M |
| Net Other Financing Charges | -$12.13M | -$20.85M | -$10.54M | -$36.49M | -$11.18M |
| Ending Cash Balance | $47.97M | $37.33M | $35.03M | $40.82M | $40.82M |
| Net Change in Cash | $10.58M | $2.43M | -$4.97M | $13.91M | $1.85M |
| Beginning Cash Balance | $37.33M | $35.03M | $40.82M | $24.46M | $38.93M |
| Effect of Exchange Rate Changes | $61,000.00 | -$129,000.00 | -$814,000.00 | $2.45M | $34,000.00 |
| Free Cash Flow | $46.73M | $34.16M | $10.58M | $150.88M | $41.22M |
| -Change In Other Working Capital | – | – | – | -$558,000.00 | – |
| Net Other Investing Changes | – | – | – | -$1.15M | -$2.00M |
No comments yet — be the first to weigh in on CNMD.
Sign in to join the discussion.